Piper Sandler raised the firm’s price target on UnitedHealth to $584 from $580 and keeps an Overweight rating on the shares. The firm notes UnitedHealth reported a Q3 revenue, MLR and EPS beat on Friday morning. The company raised CY23 guidance for the third time this year and endorsed consensus 2024 EPS, Piper adds. In a higher-for-longer world, the firm thinks UnitedHealth deserves a 2-3-times premium to the S&P.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on UNH:
- UBS upgrades UnitedHealth to Buy after ‘clearing event’
- UnitedHealth upgraded to Buy from Neutral at UBS
- Evercore ISI says CVS ‘big winner’ as Med Adv star quality ratings go live
- UnitedHealth Stock (NYSE:UNH): Beat-and-Raise is What the Doctor Ordered
- Unusually active option classes on open October 13th